Home / Health / Middle East War Fuels UK Drug Shortages
Middle East War Fuels UK Drug Shortages
2 Nov
Summary
- Middle East conflict disrupts shipping, adding 10-14 days to transit times.
- UK imports 75% of medicines, mainly from India and China.
- Shortages risk patient safety, prompting calls for prescription flexibility.
The war in the Middle East is creating significant medication shortages across the UK, as Britain imports approximately 75% of its medicines, with a substantial portion originating from India and China. Current maritime blockades and airspace closures in the region are extending medication transit times by an additional 10 to 14 days, leading to critical delivery backlogs. This situation exacerbates existing pressures on pharmacies, which are struggling to source necessary drugs and facing increased financial strain due to rising import costs.
The extended shipping routes and geopolitical instability have inflated overheads, directly increasing the cost of importing medications and essential raw materials. Health organizations, including the Royal College of GPs (RCGP), have described the shortages as among the most severe ever encountered, posing a serious risk to patient safety. The RCGP has previously supported empowering pharmacists to alter prescriptions for unavailable medications, a measure aimed at reducing patient back-and-forth with GPs and ensuring timely access to necessary treatments.
